The DOI matches its Crossref record.
Balance between IL-1 beta, TNF-alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells, and monocytes.
Abstract
Patients with end-stage renal disease present an immunodeficiency that paradoxically coexists with activation of most immunocompetent cells, and the roles of chronic uremia and maintenance dialysis are poorly understood. We determined circulating levels of IL-1 beta and IL-1Ra, TNF-alpha and its soluble receptors (TNF-sR55 and TNF-sR75), and activation markers of T cells (soluble CD25), B cells (soluble CD23), and monocytes (neopterin) in a large cohort of undialyzed patients at various stages of chronic renal failure and in dialyzed patients on maintenance hemodialysis or chronic peritoneal dialysis. The progression of uremia was associated with a gradual increase in soluble CD25, CD23, and especially neopterin levels. Although IL-1 beta could not be detected, IL-1Ra levels were significantly increased from the earliest stage of renal failure. Plasma levels of TNF-alpha, TNF-sR55, and TNF-sR75 progressed with the severity of renal failure and correlated with soluble CD25, CD23, and neopterin levels, whereas IL-1Ra levels correlated exclusively with TNF-sR55 levels. Compared with undialyzed patients, levels of IL-1 beta were higher in patients on maintenance hemodialysis, whereas those of IL-1Ra were lower and decreased further at the end of dialysis sessions. In contrast, both TNF-sR55 and TNF-sR75 levels were significantly higher than in undialyzed patients and increased further at the end of dialysis sessions in the absence of an increase of TNF-alpha. Such an imbalance between cytokines and their inhibitors may play a pivotal role in the multifaceted process of immune dysfunction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Advanced oxidation protein products as a novel marker of oxidative stress in uremia
Witko-Sarsat, V., Friedlander, M., Capeillère-Blandin, C., Nguyen-Khoa, T., Nguyen, A. T., Zingraff, J., Jungers, P., & Descamps-Latscha, B. (1996) · Kidney International · doi:10.1038/ki.1996.186 · Cited by 1,999
Self-citationReview on uremic toxins: Classification, concentration, and interindividual variability
Vanholder, R., For the European Uremic Toxin Work Group (EUTox), De Smet, R., Glorieux, G., Argilés, A., Baurmeister, U., Brunet, P., Clark, W., Cohen, G., De Deyn, P. P., et al. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00924.x · Cited by 1,720
Self-citationNeutrophils: Molecules, Functions and Pathophysiological Aspects
Witko-Sarsat, V., Rieu, P., Descamps-Latscha, B., Lesavre, P., & Halbwachs-Mecarelli, L. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780067 · Cited by 1,135
Self-citationStenvinkel, P., Ketteler, M., Johnson, R. J., Lindholm, B., Pecoits-Filho, R., Riella, M., Heimbürger, O., Cederholm, T., & Girndt, M. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00200.x · Cited by 932
Witko-Sarsat, V., Friedlander, M., Khoa, T. N., Capeillère-Blandin, C., Nguyen, A. T., Canteloup, S., Dayer, J.-M., Jungers, P., Drüeke, T., & Descamps-Latscha, B. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.5.2524 · Cited by 878
Self-citationOberg, B. P., McMenamin, E., Lucas, F. L., McMonagle, E., Morrow, J., Ikizler, T. A. L. P., & Himmelfarb, J. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00465.x · Cited by 781
The balance between IL-1 and IL-1Ra in disease
Arend, W. P. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(02)00020-5 · Cited by 721
Association between Albuminuria, Kidney Function, and Inflammatory Biomarker Profile in CKD in CRIC
Gupta, J., Mitra, N., Kanetsky, P. A., Devaney, J., Wing, M. R., Reilly, M., Shah, V. O., Balakrishnan, V. S., Guzman, N. J., Girndt, M., et al. (2012) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03500412 · Cited by 603
Schocken, D. D., Benjamin, E. J., Fonarow, G. C., Krumholz, H. M., Levy, D., Mensah, G. A., Narula, J., Shor, E. S., Young, J. B., & Hong, Y. (2008) · Circulation · doi:10.1161/circulationaha.107.188965 · Cited by 552
Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals
Fried, L. F., Shlipak, M. G., Crump, C., Kronmal, R. A., Bleyer, A. J., Gottdiener, J. S., Kuller, L. H., & Newman, A. B. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00163-3 · Cited by 535
Inflammation, Malnutrition, and Cardiac Disease as Predictors of Mortality in Hemodialysis Patients
Qureshi, A. R., Alvestrand, A., Divino-Filho, J. A. A. C., Gutierrez, A., Heimbu[Combining Diaeresis]rger, O., Lindholm, B., & Bergstro[Combining Diaeresis]m, J. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v13suppl_1s28 · Cited by 488
Mange, K. C., Joffe, M. M., & Feldman, H. I. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441004 · Cited by 483
Associations between circulating inflammatory markers and residual renal function in CRF patients
Pecoits-Filho, R., Heimbürger, O., Bárány, P., Suliman, M., Fehrman-Ekholm, I., Lindholm, B., & Stenvinkel, P. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00353-6 · Cited by 448
Review Articles: Inflammation in End‐stage Renal Disease: Sources, Consequences, and Therapy
Stenvinkel, P., & Alvestrand, A. (2002) · Seminars in Dialysis · doi:10.1046/j.1525-139x.2002.00083.x · Cited by 425
Basic Science and Dialysis: Disturbances of Acquired Immunity in Hemodialysis Patients
Eleftheriadis, T., Antoniadi, G., Liakopoulos, V., Kartsios, C., & Stefanidis, I. (2007) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2007.00283.x · Cited by 323
Landray, M. J., Wheeler, D. C., Lip, G. Y. H., Newman, D. J., Blann, A. D., McGlynn, F. J., Ball, S., Townend, J. N., & Baigent, C. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2003.10.037 · Cited by 318
Barreto, D. V., Barreto, F. C., Liabeuf, S., Temmar, M., Lemke, H.-D., Tribouilloy, C., Choukroun, G., Vanholder, R., & Massy, Z. A. (2010) · Kidney International · doi:10.1038/ki.2009.503 · Cited by 311
Turkmen, K., Erdur, F. M., Ozcicek, F., Ozcicek, A., Akbas, E. M., Ozbicer, A., Demirtas, L., Turk, S., & Tonbul, H. Z. (2013) · Hemodialysis International · doi:10.1111/hdi.12040 · Cited by 309
Ohtake, T., Kobayashi, S., Moriya, H., Negishi, K., Okamoto, K., Maesato, K., & Saito, S. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004090765 · Cited by 283
Uremic Toxicity: Present State of the Art
Vanholder, R., Argilés, A., Baurmeister, U., Brunet, P., Clark, W., Cohen, G., Dedeyn, P. P., Deppisch, R., Descamps-Latscha, B., Henle, T., et al. (2001) · The International Journal of Artificial Organs · doi:10.1177/039139880102401004 · Cited by 281
Self-citationSTUDNICKA-BENKE, A., STEINER, G., PETERA, P., & SMOLEN, J. S. (1996) · Rheumatology · doi:10.1093/rheumatology/35.11.1067 · Cited by 280
Weiss, G., Meusburger, E., Radacher, G., Garimorth, K., Neyer, U., & Mayer, G. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00099.x · Cited by 105
Cooker, L. A., Peterson, D., Rambow, J., Riser, M. L., Riser, R. E., Najmabadi, F., Brigstock, D., & Riser, B. L. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00508.2006 · Cited by 60
Mechanism underlying renal failure caused by pathogenic Candida albicans infection
JAE-CHEN, S., YOUNG-JOO, J., SEON-MIN, P., KANG SEOK, S., JUNG-HYUN, S., & JUNG-IL, C. (2015) · Biomedical Reports · doi:10.3892/br.2014.393 · Cited by 18
Metadata
- Authors
- Descamps-Latscha, B., Herbelin, A., Nguyen, A. T., Roux-Lombard, P., Zingraff, J., Moynot, A., Verger, C., Dahmane, D., de Groote, D., Jungers, P., & Dayer, J.-M.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1995-01
- Volume
- 154
- Issue
- 2
- Pages
- 882-892
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1681070212
- Cited by
- 332
- References
- 0
- FWCI
- 6.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.